Klobuch, Sebastian http://orcid.org/0000-0003-1364-0763
Weber, Daniela
Holler, Barbara
Edinger, Matthias
Herr, Wolfgang
Holler, Ernst
Wolff, Daniel
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (collaborative research center 221, individual project B10)
Article History
Received: 13 January 2019
Accepted: 25 July 2019
First Online: 3 August 2019
Compliance with ethical standards
:
: This work was funded by the german research foundation, collaborative research center 221, individual project B10 (Daniel Wolff).
: Daniel Wolff received honoraria from Mallinckrodt, Novartis, Shire and Neovii. All other authors declare no conflict of interest.
: Because our study was a retrospective analysis, no additional ethical approval of the institutional committee was necessary.
: Informed consent to receive rituximab was obtained from all individual participants included in the study.